Studies of the effects of central administration of beta-amyloid peptide (25-35): pathomorphological changes in the Hippocampus and impairment of spatial memory.

Source:http://linkedlifedata.com/resource/pubmed/id/16328175

Download in:

View as

General Info

PMID
16328175